Isodiol International Inc. Announces Partnership with Powerhouse Gym as Preferred CBD Vendor with Iso-Sport Cannabis Investing News
SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency Biotech Investing
VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals Biotech Investing
Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative Pharmaceutical Investing
Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury Biotech Investing
EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress Life Science Investing
Shire Granted EU Marketing Authorization for Veyvondi for Adults With Von Willebrand Disease Biotech Investing
